PubMed

Importance of mucosal healing in ulcerative colitis.

Lichtenstein GR, Rutgeerts P.

Inflamm Bowel Dis. 2009 Jul 27. [Epub ahead of print]PMID: 19637362 [PubMed - as supplied by publisher]Related articles

Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.

Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, Lu J, Horgan K, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF.

Gastroenterology. 2009 Oct;137(4):1250-60; quiz 1520. Epub 2009 Jul 28.PMID: 19596014 [PubMed - indexed for MEDLINE]Related articles

Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials.

Lichtenstein GR, Diamond RH, Wagner CL, Fasanmade AA, Olson AD, Marano CW, Johanns J, Lang Y, Sandborn WJ.

Aliment Pharmacol Ther. 2009 Aug;30(3):210-26. Epub 2009 Apr 21.PMID: 19392858 [PubMed - in process]Related articles

Reformulation of an aminosalicylate: an example of the importance of pill burden on medical compliance rates.

Osterman MT, Lichtenstein GR.

Methods Find Exp Clin Pharmacol. 2009 Jan-Feb;31(1):41-6. Review.PMID: 19357797 [PubMed - indexed for MEDLINE]Related articles

Management of Crohn's disease in adults.

Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology.

Am J Gastroenterol. 2009 Feb;104(2):465-83; quiz 464, 484. Epub 2009 Jan 6.PMID: 19174807 [PubMed - indexed for MEDLINE]Related articles

Mesalamine with MMX technology for the treatment of ulcerative colitis.

Schreiber S, Kamm MA, Lichtenstein GR.

Expert Rev Gastroenterol Hepatol. 2008 Jun;2(3):299-314. Review.PMID: 19072380 [PubMed - indexed for MEDLINE]Related articles

Oral budesonide for maintenance of remission of Crohn's disease: a pooled safety analysis.

Lichtenstein GR, Bengtsson B, Hapten-White L, Rutgeerts P.

Aliment Pharmacol Ther. 2009 Mar 15;29(6):643-53. Epub 2008 Nov 13.PMID: 19035972 [PubMed - indexed for MEDLINE]Related articles

Effect of extended MMX mesalamine therapy for acute, mild-to-moderate ulcerative colitis.

Kamm MA, Lichtenstein GR, Sandborn WJ, Schreiber S, Lees K, Barrett K, Joseph R.

Inflamm Bowel Dis. 2009 Jan;15(1):1-8.PMID: 18671232 [PubMed - indexed for MEDLINE]Related articles

Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis.

Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, Ellenberg JH.

Inflamm Bowel Dis. 2008 Dec;14(12):1660-6.PMID: 18623174 [PubMed - indexed for MEDLINE]Related articles

High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis.

Blonski W, Kundu R, Furth EF, Lewis J, Aberra F, Lichtenstein GR.

Scand J Gastroenterol. 2008;43(7):817-20.PMID: 18584520 [PubMed - indexed for MEDLINE]Related articles

Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?

Blonski W, Kundu R, Lewis J, Aberra F, Osterman M, Lichtenstein GR.

Scand J Gastroenterol. 2008;43(6):698-703.PMID: 18569987 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn's disease.

Pascua M, Su C, Lewis JD, Brensinger C, Lichtenstein GR.

Aliment Pharmacol Ther. 2008 Sep 1;28(5):545-56. Epub 2008 Jun 28.PMID: 18565159 [PubMed - indexed for MEDLINE]Related articles

Review article: 5-aminosalicylate formulations for the treatment of ulcerative colitis--methods of comparing release rates and delivery of 5-aminosalicylate to the colonic mucosa.

Lichtenstein GR, Kamm MA.

Aliment Pharmacol Ther. 2008 Sep 15;28(6):663-73. Review.PMID: 18532992 [PubMed - indexed for MEDLINE]Related articles

Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitis.

Lichtenstein GR, Rubin DT, Sabesin SM, Velayos FS, Vitat P.

Rev Gastroenterol Disord. 2008 Winter;8(1):21-30; quiz 31-2. Review.PMID: 18477967 [PubMed - indexed for MEDLINE]Related articles

MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations.

Lichtenstein GR, Kamm MA, Sandborn WJ, Lyne A, Joseph RE.

Aliment Pharmacol Ther. 2008 Jun 1;27(11):1094-102. Epub 2008 Mar 22.PMID: 18363894 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.

Lewis JD, Lichtenstein GR, Deren JJ, Sands BE, Hanauer SB, Katz JA, Lashner B, Present DH, Chuai S, Ellenberg JH, Nessel L, Wu GD; Rosiglitazone for Ulcerative Colitis Study Group.

Gastroenterology. 2008 Mar;134(3):688-95. Epub 2007 Dec 7.PMID: 18325386 [PubMed - indexed for MEDLINE]Related articlesFree article

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis.

Kamm MA, Lichtenstein GR, Sandborn WJ, Schreiber S, Lees K, Barrett K, Joseph R.

Gut. 2008 Jul;57(7):893-902. Epub 2008 Feb 13.PMID: 18272546 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized, controlled, double-blind trial of patient-controlled sedation with propofol/remifentanil versus midazolam/fentanyl for colonoscopy.

Mandel JE, Tanner JW, Lichtenstein GR, Metz DC, Katzka DA, Ginsberg GG, Kochman ML.

Anesth Analg. 2008 Feb;106(2):434-9, table of contents.PMID: 18227297 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical trial: sodium phosphate tablets are preferred and better tolerated by patients compared to polyethylene glycol solution plus bisacodyl tablets for bowel preparation.

Lichtenstein GR, Grandhi N, Schmalz M, Lottes SR, Forbes WP, Walker K, Zhang B.

Aliment Pharmacol Ther. 2007 Nov 15;26(10):1361-70.PMID: 17983368 [PubMed - indexed for MEDLINE]Related articlesFree article

Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update.

Rubin DT, Cruz-Correa MR, Gasche C, Jass JR, Lichtenstein GR, Montgomery EA, Riddell RH, Rutter MD, Ullman TA, Velayos FS, Itzkowitz S; 5-ASA in Colorectal Cancer Prevention Meeting Group.

Inflamm Bowel Dis. 2008 Feb;14(2):265-74. Review.PMID: 17932965 [PubMed - indexed for MEDLINE]Related articlesFree article

Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.

Sandborn WJ, Feagan BG, Lichtenstein GR.

Aliment Pharmacol Ther. 2007 Oct 1;26(7):987-1003. Review.PMID: 17877506 [PubMed - indexed for MEDLINE]Related articlesFree article

Review article: Bowel preparation for colonoscopy--the importance of adequate hydration.

Lichtenstein GR, Cohen LB, Uribarri J.

Aliment Pharmacol Ther. 2007 Sep 1;26(5):633-41. Review.PMID: 17697197 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk for active tuberculosis in inflammatory bowel disease patients.

Aberra FN, Stettler N, Brensinger C, Lichtenstein GR, Lewis JD.

Clin Gastroenterol Hepatol. 2007 Sep;5(9):1070-5. Epub 2007 Jul 12.PMID: 17627901 [PubMed - indexed for MEDLINE]Related articles

MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials.

Sandborn WJ, Kamm MA, Lichtenstein GR, Lyne A, Butler T, Joseph RE.

Aliment Pharmacol Ther. 2007 Jul 15;26(2):205-15.PMID: 17593066 [PubMed - indexed for MEDLINE]Related articlesFree article

Bowman-Birk inhibitor concentrate: a novel therapeutic agent for patients with active ulcerative colitis.

Lichtenstein GR, Deren JJ, Katz S, Lewis JD, Kennedy AR, Ware JH.

Dig Dis Sci. 2008 Jan;53(1):175-80. Epub 2007 Jun 6.PMID: 17551835 [PubMed - indexed for MEDLINE]Related articles

Current and Future Anti-TNF Therapy for Inflammatory Bowel Disease.

Osterman MT, Lichtenstein GR.

Curr Treat Options Gastroenterol. 2007 Jun;10(3):195-207.PMID: 17547858 [PubMed - in process]Related articles

Safety of biologic therapy.

Blonski W, Lichtenstein GR.

Inflamm Bowel Dis. 2007 Jun;13(6):769-96. Review.PMID: 17304581 [PubMed - indexed for MEDLINE]Related articlesFree article

A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis.

Su C, Lewis JD, Goldberg B, Brensinger C, Lichtenstein GR.

Gastroenterology. 2007 Feb;132(2):516-26. Epub 2006 Dec 20. Review.PMID: 17258720 [PubMed - indexed for MEDLINE]Related articles

Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.

Lichtenstein GR, Kamm MA, Boddu P, Gubergrits N, Lyne A, Butler T, Lees K, Joseph RE, Sandborn WJ.

Clin Gastroenterol Hepatol. 2007 Jan;5(1):95-102.PMID: 17234558 [PubMed - indexed for MEDLINE]Related articles

[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease]

Lichtenstein GR, Sbreu MT, Cohen R, Tremaine W.

Rev Gastroenterol Mex. 2006 Jul-Sep;71(3):351-401. Review. Spanish. No abstract available. PMID: 17140062 [PubMed - indexed for MEDLINE]Related articles

Infliximab in ulcerative colitis.

Aberra FN, Lichtenstein GR.

Gastroenterol Clin North Am. 2006 Dec;35(4):821-36. Review.PMID: 17129815 [PubMed - indexed for MEDLINE]Related articles

Infliximab in fistulizing Crohn's disease.

Osterman MT, Lichtenstein GR.

Gastroenterol Clin North Am. 2006 Dec;35(4):795-820. Review.PMID: 17129814 [PubMed - indexed for MEDLINE]Related articles

Chemokines and cytokines in inflammatory bowel disease and their application to disease treatment.

Lichtenstein GR.

Curr Opin Gastroenterol. 2000 Jan;16(1):83-8.PMID: 17024022 [PubMed]Related articles

Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.

Chan EP, Lichtenstein GR.

Gastroenterol Clin North Am. 2006 Sep;35(3):675-712. Review.PMID: 16952746 [PubMed - indexed for MEDLINE]Related articles

Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis.

Lichtenstein GR, Cohen R, Yamashita B, Diamond RH.

J Clin Gastroenterol. 2006 Sep;40(8):669-77. Review.PMID: 16940876 [PubMed - indexed for MEDLINE]Related articles

Prevention and treatment of osteoporosis in inflammatory bowel disease.

Lichtenstein GR, Sands BE, Pazianas M.

Inflamm Bowel Dis. 2006 Aug;12(8):797-813. Review.PMID: 16917235 [PubMed - indexed for MEDLINE]Related articles

Thoracic spine spasms secondary to hemorrhagic intestinal ulcer.

Slipman CW, Whyte Ii WS, Lichtenstein GR, Lenrow D, Braverman D, Ellen M, Vresilovic EJ.

Pain Physician. 2001 Jan;4(1):97-100.PMID: 16906172 [PubMed]Related articlesFree article

Safety of biologics in inflammatory bowel disease.

Blonski W, Lichtenstein GR.

Curr Treat Options Gastroenterol. 2006 Jun;9(3):221-33.PMID: 16901386 [PubMed - in process]Related articles

The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn's disease.

Pazianas M, Rhim AD, Weinberg AM, Su C, Lichtenstein GR.

Ann N Y Acad Sci. 2006 Apr;1068:543-56.PMID: 16831950 [PubMed - indexed for MEDLINE]Related articles

Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.

Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Chen DM, Pritchard ML, Sandborn WJ.

Clin Gastroenterol Hepatol. 2006 May;4(5):621-30. Erratum in: Clin Gastroenterol Hepatol. 2006 Jul;4(7):931. PMID: 16678077 [PubMed - indexed for MEDLINE]Related articles

Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis.

Osterman MT, Kundu R, Lichtenstein GR, Lewis JD.

Gastroenterology. 2006 Apr;130(4):1047-53.PMID: 16618398 [PubMed - indexed for MEDLINE]Related articles

The impact of increased body mass index on the clinical course of Crohn's disease.

Hass DJ, Brensinger CM, Lewis JD, Lichtenstein GR.

Clin Gastroenterol Hepatol. 2006 Apr;4(4):482-8.PMID: 16616354 [PubMed - indexed for MEDLINE]Related articles

Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.

Lichtenstein GR, Olson A, Travers S, Diamond RH, Chen DM, Pritchard ML, Feagan BG, Cohen RD, Salzberg BA, Hanauer SB, Sandborn WJ.

Am J Gastroenterol. 2006 May;101(5):1030-8.PMID: 16606351 [PubMed - indexed for MEDLINE]Related articles

Drug insight: antagonists of tumor-necrosis factor-alpha in the treatment of inflammatory bowel disease.

Chang JT, Lichtenstein GR.

Nat Clin Pract Gastroenterol Hepatol. 2006 Apr;3(4):220-8. Review.PMID: 16582964 [PubMed - indexed for MEDLINE]Related articles

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.

Lichtenstein GR, Abreu MT, Cohen R, Tremaine W; American Gastroenterological Association.

Gastroenterology. 2006 Mar;130(3):940-87. Review. No abstract available. PMID: 16530532 [PubMed - indexed for MEDLINE]Related articles

American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.

Lichtenstein GR, Abreu MT, Cohen R, Tremaine W; American Gastroenterological Association.

Gastroenterology. 2006 Mar;130(3):935-9. No abstract available. PMID: 16530531 [PubMed - indexed for MEDLINE]Related articles

Infliximab treatment of postoperative ulcers in Crohn's disease: to inject or not to inject--that is the question.

Blonski W, Lichtenstein GR.

Gastrointest Endosc. 2006 Mar;63(3):493-6. No abstract available. PMID: 16500403 [PubMed - indexed for MEDLINE]Related articles

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.

Rutgeerts P, Diamond RH, Bala M, Olson A, Lichtenstein GR, Bao W, Patel K, Wolf DC, Safdi M, Colombel JF, Lashner B, Hanauer SB.

Gastrointest Endosc. 2006 Mar;63(3):433-42; quiz 464.PMID: 16500392 [PubMed - indexed for MEDLINE]Related articles

Advances in gastrointestinal pharmacotherapy.

Metz DC, Vakil N, Keeffe EB, Lichtenstein GR.

Clin Gastroenterol Hepatol. 2005 Dec;3(12):1167-79. Review.PMID: 16361040 [PubMed - indexed for MEDLINE]Related articles

Infliximab for induction and maintenance therapy for ulcerative colitis.

Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF.

N Engl J Med. 2005 Dec 8;353(23):2462-76. Erratum in: N Engl J Med. 2006 May 18;354(20):2200. PMID: 16339095 [PubMed - indexed for MEDLINE]Related articlesFree article